Anselamimab

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Approval Year

Name

Type

Language

Anselamimab

Official Name

English

ANSELAMIMAB [USAN]

Common Name

English

IMMUNOGLOBULIN G1, ANTI-(HUMAN AMYLOID FIBRIL) (HUMAN-MUS MUSCULUS MONOCLONAL CAEL-101 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL CAEL-101 .KAPPA.-CHAIN, DIMER

Common Name

English

CAEL-101

Code

English

11-1F4

Common Name

English

Chimeric fibril reactive monoclonal antibody 11-1F4

Common Name

English

anselamimab [INN]

Common Name

English

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS IMMUNOGLOBULIN LIGHT CHAIN AMYLOID (AL) FIBRILS), CHIMERIC MONOCLONAL ANTIBODY (GAMMA1 HEAVY CHAIN CHIMERIC (1-441) (MUS MUSCULUS VH (IGHV2-3*01 (92.6%)-(IGHD)-IGHJ4*01 (92.9%), CDR-IMGT (8.7.5) (26-33.51-57.96

Common Name

English

Classification Tree Code System Code

FDA ORPHAN DRUG

290309

Created by admin on Sat Dec 16 18:50:28 GMT 2023 , Edited by admin on Sat Dec 16 18:50:28 GMT 2023

FDA ORPHAN DRUG

293709

Created by admin on Sat Dec 16 18:50:28 GMT 2023 , Edited by admin on Sat Dec 16 18:50:28 GMT 2023

Code System Code Type Description

FDA UNII

TL94QQ5RTW

Created by admin on Sat Dec 16 18:50:28 GMT 2023 , Edited by admin on Sat Dec 16 18:50:28 GMT 2023

PRIMARY

USAN

LM-147

Created by admin on Sat Dec 16 18:50:28 GMT 2023 , Edited by admin on Sat Dec 16 18:50:28 GMT 2023

PRIMARY

NCI_THESAURUS

C117241

Created by admin on Sat Dec 16 18:50:28 GMT 2023 , Edited by admin on Sat Dec 16 18:50:28 GMT 2023

PRIMARY

CAS

2414866-63-8

Created by admin on Sat Dec 16 18:50:28 GMT 2023 , Edited by admin on Sat Dec 16 18:50:28 GMT 2023

PRIMARY

INN

11703

Created by admin on Sat Dec 16 18:50:28 GMT 2023 , Edited by admin on Sat Dec 16 18:50:28 GMT 2023

PRIMARY

ACTIVE MOIETY


					TL94QQ5RTW